Leuthold Group LLC Has $10.25 Million Stock Holdings in Cardinal Health, Inc. $CAH

Leuthold Group LLC lowered its position in Cardinal Health, Inc. (NYSE:CAH) by 1.5% during the second quarter, HoldingsChannel.com reports. The firm owned 61,036 shares of the company’s stock after selling 918 shares during the quarter. Cardinal Health makes up approximately 1.2% of Leuthold Group LLC’s holdings, making the stock its 17th largest holding. Leuthold Group LLC’s holdings in Cardinal Health were worth $10,254,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CAH. Atlantic Edge Private Wealth Management LLC grew its stake in shares of Cardinal Health by 75.0% in the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock valued at $29,000 after buying an additional 75 shares in the last quarter. Greykasell Wealth Strategies Inc. acquired a new stake in Cardinal Health in the first quarter valued at approximately $26,000. Vermillion & White Wealth Management Group LLC grew its position in Cardinal Health by 55.0% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock worth $34,000 after acquiring an additional 71 shares in the last quarter. NewSquare Capital LLC increased its stake in shares of Cardinal Health by 100.0% during the 2nd quarter. NewSquare Capital LLC now owns 214 shares of the company’s stock worth $36,000 after purchasing an additional 107 shares during the last quarter. Finally, AlphaCore Capital LLC bought a new position in shares of Cardinal Health during the 2nd quarter valued at $41,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $212.26 on Friday. The company has a market cap of $50.43 billion, a PE ratio of 32.91, a price-to-earnings-growth ratio of 1.39 and a beta of 0.72. The firm has a fifty day moving average price of $177.57 and a two-hundred day moving average price of $163.40. Cardinal Health, Inc. has a fifty-two week low of $114.60 and a fifty-two week high of $214.93.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business had revenue of $64.01 billion during the quarter, compared to analysts’ expectations of $59.41 billion. During the same quarter last year, the company earned $1.88 earnings per share. The firm’s revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Friday, January 2nd. Cardinal Health’s payout ratio is 30.77%.

Analysts Set New Price Targets

Several research firms have commented on CAH. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, October 8th. Wall Street Zen raised Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. TD Cowen upped their target price on Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, November 3rd. Finally, Mizuho increased their price target on Cardinal Health from $170.00 to $210.00 and gave the company an “outperform” rating in a report on Monday, November 3rd. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $206.57.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.